Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aiello, L. P.
Right arrow Articles by King, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aiello, L. P.
Right arrow Articles by King, G. L.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 9 1473-1480, Copyright © 1997 by American Diabetes Association

ARTICLES

Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor

LP Aiello, SE Bursell, A Clermont, E Duh, H Ishii, C Takagi, F Mori, TA Ciulla, K Ways, M Jirousek, LE Smith and GL King
Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

Increased vascular permeability and excessive neovascularization are the hallmarks of endothelial dysfunction, which can lead to diabetic macular edema and proliferative diabetic retinopathy in the eye. Vascular endothelial growth factor (VEGF) is an important mediator of ocular neovascularization and a known vasopermeability factor in nonocular tissues. In these studies, we demonstrate that intravitreal injection of VEGF rapidly activates protein kinase C (PKC) in the retina at concentrations observed clinically, inducing membrane translocation of PKC isoforms alpha, betaII, and delta and >threefold increases in retinal vasopermeability in vivo. The effect of VEGF on retinal vascular permeability appears to be mediated predominantly by the beta-isoform of PKC with >95% inhibition of VEGF-induced permeability by intravitreal or oral administration of a PKC beta-isoform-selective inhibitor that did not inhibit histamine-mediated effects. These studies represent the first direct demonstration that VEGF can increase intraocular vascular permeability through activation of PKC in vivo and suggest that oral pharmacological therapies involving PKC beta-isoform-selective inhibitors may prove efficacious for the treatment of VEGF-associated ocular disorders such as diabetic retinopathy.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 IOVSHome page
E. J. Kuiper, J. M. Hughes, R. J. Van Geest, I. M. C. Vogels, R. Goldschmeding, C. J. F. Van Noorden, R. O. Schlingemann, and I. Klaassen
Effect of VEGF-A on Expression of Profibrotic Growth Factor and Extracellular Matrix Genes in the Retina
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4267 - 4276.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. M. Rademaker-Lakhai, L. V. Beerepoot, N. Mehra, S. A. Radema, R. van Maanen, J. S. Vermaat, E. O. Witteveen, C. M. Visseren-Grul, L. Musib, N. Enas, et al.
Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C {beta}-Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer
Clin. Cancer Res., August 1, 2007; 13(15): 4474 - 4481.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. J. Kelly, D. Buck, A. J. Cox, Y. Zhang, and R. E. Gilbert
Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F565 - F574.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Ding, A. Kantarci, J. A. Badwey, H. Hasturk, A. Malabanan, and T. E. Van Dyke
Phosphorylation of Pleckstrin Increases Proinflammatory Cytokine Secretion by Mononuclear Phagocytes in Diabetes Mellitus
J. Immunol., July 1, 2007; 179(1): 647 - 654.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
K. Lu, Y. Zhou, K. Kaufman, R. Mott, and J.-x. Ma
Rat strain-dependent susceptibility to ischemia-induced retinopathy associated with retinal vascular endothelial growth factor regulation
J. Mol. Endocrinol., April 1, 2007; 38(4): 423 - 432.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Simo, E. Carrasco, A. Fonollosa, J. Garcia-Arumi, R. Casamitjana, and C. Hernandez
Deficit of Somatostatin in the Vitreous Fluid of Patients With Diabetic Macular Edema
Diabetes Care, March 1, 2007; 30(3): 725 - 727.
[Full Text] [PDF]

Home page
 Arch OphthalmolHome page
The PKC-DMES Study Group
Effect of Ruboxistaurin in Patients With Diabetic Macular Edema: Thirty-Month Results of the Randomized PKC-DMES Clinical Trial
Arch Ophthalmol, March 1, 2007; 125(3): 318 - 324.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. S. Harhaj, E. A. Felinski, E. B. Wolpert, J. M. Sundstrom, T. W. Gardner, and D. A. Antonetti
VEGF Activation of Protein Kinase C Stimulates Occludin Phosphorylation and Contributes to Endothelial Permeability
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5106 - 5115.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
S.-F. Yan, E. Harja, M. Andrassy, T. Fujita, and A. M. Schmidt
Protein Kinase C {beta}/Early Growth Response-1 Pathway: A Key Player in Ischemia, Atherosclerosis, and Restenosis
J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A47 - A55.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. Yamagata, S. L. Rook, Y. Sassa, R. C. Ma, P. Geraldes, L. Goddard, A. Clermont, B. Gao, H. Salti, R. Gundel, et al.
Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects
FASEB J, October 1, 2006; 20(12): 2058 - 2067.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Hernandez, A. Fonollosa, M. Garcia-Ramirez, M. Higuera, R. Catalan, A. Miralles, J. Garcia-Arumi, and R. Simo
Erythropoietin Is Expressed in the Human Retina and It Is Highly Elevated in the Vitreous Fluid of Patients With Diabetic Macular Edema.
Diabetes Care, September 1, 2006; 29(9): 2028 - 2033.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
S. X Zhang, J. J Wang, G. Gao, K. Parke, and J.-x. Ma
Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
J. Mol. Endocrinol., August 1, 2006; 37(1): 1 - 12.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
I. Semkova, S. Fauser, A. Lappas, N. Smyth, N. Kociok, B. Kirchhof, M. Paulsson, V. Poulaki, and A. M. Joussen
Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization
FASEB J, August 1, 2006; 20(10): 1689 - 1691.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. C. Clermont, M. Cahill, H. Salti, S. L. Rook, C. Rask-Madsen, L. Goddard, J. S. Wong, D. Bursell, S. E. Bursell, and L. P. Aiello
Hepatocyte Growth Factor Induces Retinal Vascular Permeability via MAP-Kinase and PI-3 Kinase without Altering Retinal Hemodynamics.
Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2701 - 2708.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. G. Shaw, J. P. Boden, E. Biecker, J. Reichen, and B. Rothen
Endothelin Antagonism Prevents Diabetic Retinopathy in NOD Mice: A Potential Role of the Angiogenic Factor Adrenomedullin.
Experimental Biology and Medicine, June 1, 2006; 231(6): 1101 - 1105.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
K. B. Sotiropoulos, A. Clermont, Y. Yasuda, C. Rask-Madsen, M. Mastumoto, J. Takahashi, K. Della Vecchia, T. Kondo, L. P. Aiello, and G. L. King
Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPAR{gamma} agonist's effects on edema and weight gain
FASEB J, June 1, 2006; 20(8): 1203 - 1205.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. J. Barbuch, K. Campanale, C. E. Hadden, M. Zmijewski, P. Yi, D. D. O'Bannon, J. L. Burkey, and P. Kulanthaivel
IN VIVO METABOLISM OF [14C]RUBOXISTAURIN IN DOGS, MICE, AND RATS FOLLOWING ORAL ADMINISTRATION AND THE STRUCTURE DETERMINATION OF ITS METABOLITES BY LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY AND NMR SPECTROSCOPY
Drug Metab. Dispos., February 1, 2006; 34(2): 213 - 224.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
S. X. Zhang, J. J. Wang, K. Lu, R. Mott, R. Longeras, and J.-x. Ma
Therapeutic Potential of Angiostatin in Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 475 - 486.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
L. P. Aiello, A. Clermont, V. Arora, M. D. Davis, M. J. Sheetz, and S.-E. Bursell
Inhibition of PKC {beta} by Oral Administration of Ruboxistaurin Is Well Tolerated and Ameliorates Diabetes-Induced Retinal Hemodynamic Abnormalities in Patients
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 86 - 92.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
T. Ojima, H. Takagi, K. Suzuma, H. Oh, I. Suzuma, H. Ohashi, D. Watanabe, E. Suganami, T. Murakami, M. Kurimoto, et al.
EphrinA1 Inhibits Vascular Endothelial Growth Factor-Induced Intracellular Signaling and Suppresses Retinal Neovascularization and Blood-Retinal Barrier Breakdown
Am. J. Pathol., January 1, 2006; 168(1): 331 - 339.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. H. Yoo, H.-J. Hyun, J.-Y. Koh, and Y. H. Yoon
Riluzole Inhibits VEGF-Induced Endothelial Cell Proliferation In Vitro and Hyperoxia-Induced Abnormal Vessel Formation In Vivo
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4780 - 4787.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Strom, B. Sander, K. Klemp, L. P. Aiello, H. Lund-Andersen, and M. Larsen
Effect of Ruboxistaurin on Blood-Retinal Barrier Permeability in Relation to Severity of Leakage in Diabetic Macular Edema
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3855 - 3858.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
The PKC-DRS Study Group
The Effect of Ruboxistaurin on Visual Loss in Patients With Moderately Severe to Very Severe Nonproliferative Diabetic Retinopathy: Initial Results of the Protein Kinase C {beta} Inhibitor Diabetic Retinopathy Study (PKC-DRS) Multicenter Randomized Clinical Trial
Diabetes, July 1, 2005; 54(7): 2188 - 2197.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. X. Zhang, J.-x. Ma, J. Sima, Y. Chen, M. S. Hu, A. Ottlecz, and G. N. Lambrou
Genetic Difference in Susceptibility to the Blood-Retina Barrier Breakdown in Diabetes and Oxygen-Induced Retinopathy
Am. J. Pathol., January 1, 2005; 166(1): 313 - 321.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
V. Thallas-Bonke, C. Lindschau, B. Rizkalla, L. A. Bach, G. Boner, M. Meier, H. Haller, M. E. Cooper, and J. M. Forbes
Attenuation of Extracellular Matrix Accumulation in Diabetic Nephropathy by the Advanced Glycation End Product Cross-Link Breaker ALT-711 via a Protein Kinase C-{alpha}-Dependent Pathway
Diabetes, November 1, 2004; 53(11): 2921 - 2930.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. J. Franklin, T. L. Jetton, C. L. Kuchemann, S. R. Russell, and E. C. Kohn
CAI Is a Potent Inhibitor of Neovascularization and Imparts Neuroprotection in a Mouse Model of Ischemic Retinopathy
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3756 - 3766.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. S. Fong, L. P. Aiello, F. L. Ferris III, and R. Klein
Diabetic Retinopathy
Diabetes Care, October 1, 2004; 27(10): 2540 - 2553.
[Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. S. Ip, J. L. Gottlieb, A. Kahana, I. U. Scott, M. M. Altaweel, B. A. Blodi, R. E. Gangnon, and C. A. Puliafito
Intravitreal Triamcinolone for the Treatment of Macular Edema Associated With Central Retinal Vein Occlusion
Arch Ophthalmol, August 1, 2004; 122(8): 1131 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
Z. F. Bashshur, R. N. Ma'luf, S. Allam, F. A. Jurdi, R. S. Haddad, and B. N. Noureddin
Intravitreal Triamcinolone for the Management of Macular Edema Due to Nonischemic Central Retinal Vein Occlusion
Arch Ophthalmol, August 1, 2004; 122(8): 1137 - 1140.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
B. A. Berkowitz, R. Roberts, H. Luan, J. Peysakhov, X. Mao, and K. A. Thomas
Dynamic Contrast-Enhanced MRI Measurements of Passive Permeability through Blood Retinal Barrier in Diabetic Rats
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2391 - 2398.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. S. Ip
Intravitreal Injection of Triamcinolone: An emerging treatment for diabetic macular edema
Diabetes Care, July 1, 2004; 27(7): 1794 - 1797.
[Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
R Donnelly, I Idris, and J V Forrester
Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research
Br. J. Ophthalmol., January 1, 2004; 88(1): 145 - 151.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
A. J. Barber and D. A. Antonetti
Mapping the Blood Vessels with Paracellular Permeability in the Retinas of Diabetic Rats
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5410 - 5416.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
T. A. Ciulla, A. G. Amador, and B. Zinman
Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies
Diabetes Care, September 1, 2003; 26(9): 2653 - 2664.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. L. Amaral, K. G. Maier, D. N. Schippers, R. J. Roman, and A. S. Greene
CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis
Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1528 - H1535.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Yokota, R. C. Ma, J.-Y. Park, K. Isshiki, K. B. Sotiropoulos, R. K. Rauniyar, K. E. Bornfeldt, and G. L. King
Role of Protein Kinase C on the Expression of Platelet-Derived Growth Factor and Endothelin-1 in the Retina of Diabetic Rats and Cultured Retinal Capillary Pericytes
Diabetes, March 1, 2003; 52(3): 838 - 845.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
Z. He, C. Rask-Madsen, and G.L. King
Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57.
[Abstract] [PDF]

Home page
 Arch OphthalmolHome page
S. R. Boyd, I. Zachary, U. Chakravarthy, G. J. Allen, G. B. Wisdom, I. A. Cree, J. F. Martin, and P. G. Hykin
Correlation of Increased Vascular Endothelial Growth Factor With Neovascularization and Permeability in Ischemic Central Vein Occlusion
Arch Ophthalmol, December 1, 2002; 120(12): 1644 - 1650.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. J. Sheetz and G. L. King
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
JAMA, November 27, 2002; 288(20): 2579 - 2588.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Flyvbjerg, F. Dagnaes-Hansen, A. S. De Vriese, B. F. Schrijvers, R. G. Tilton, and R. Rasch
Amelioration of Long-Term Renal Changes in Obese Type 2 Diabetic Mice by a Neutralizing Vascular Endothelial Growth Factor Antibody
Diabetes, October 1, 2002; 51(10): 3090 - 3094.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
The Epidemiology of Complications
Diabetes Care, May 1, 2002; 25(5): 924 - 932.
[Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
B Sander, M Larsen, C Engler, C Strom, B Moldow, N Larsen, and H Lund-Andersen
Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy
Br. J. Ophthalmol., March 1, 2002; 86(3): 316 - 320.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
K. Suzuma, N. Takahara, I. Suzuma, K. Isshiki, K. Ueki, M. Leitges, L. P. Aiello, and G. L. King
Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization
PNAS, January 22, 2002; 99(2): 721 - 726.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. Chou, I. Suzuma, K. J. Way, D. Opland, A. C. Clermont, K. Naruse, K. Suzuma, N. L. Bowling, C. J. Vlahos, L. P. Aiello, et al.
Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States: A Possible Explanation for Impaired Collateral Formation in Cardiac Tissue
Circulation, January 22, 2002; 105(3): 373 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
The New York Diabetes Association's 48th Annual Scientific Meeting, the American Diabetes Association's 48th Annual Advanced Postgraduate Course, and the Meeting of the Naomi Berry Diabetes Center of Columbia University
Diabetes Care, July 1, 2001; 24(7): 1280 - 1285.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. E. Benjamin
Glucose, VEGF-A, and Diabetic Complications
Am. J. Pathol., April 1, 2001; 158(4): 1181 - 1184.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. A. Teicher, K. Menon, E. Alvarez, E. Galbreath, C. Shih, and M. Faul
Antiangiogenic and Antitumor Effects of a Protein Kinase C{beta} Inhibitor in Human T98G Glioblastoma Multiforme Xenografts
Clin. Cancer Res., March 1, 2001; 7(3): 634 - 640.
[Abstract] [Full Text]

Home page
 Br. J. Ophthalmol.Home page
G B ARDEN
The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment
Br. J. Ophthalmol., March 1, 2001; 85(3): 366 - 370.
[Full Text]

Home page
 IOVSHome page
H. Thieme, M. Nuskovski, J. U. Nass, U. Pleyer, O. Strauss, and M. Wiederholt
Mediation of Calcium-Independent Contraction in Trabecular Meshwork through Protein Kinase C and Rho-A
Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4240 - 4246.
[Abstract] [Full Text]

Home page
 IOVSHome page
J. Baffi, G. Byrnes, C.-C. Chan, and K. G. Csaky
Choroidal Neovascularization in the Rat Induced by Adenovirus Mediated Expression of Vascular Endothelial Growth Factor
Invest. Ophthalmol. Vis. Sci., October 1, 2000; 41(11): 3582 - 3589.
[Abstract] [Full Text]

Home page
 CirculationHome page
M. Simons, R. O. Bonow, N. A. Chronos, D. J. Cohen, F. J. Giordano, H. K. Hammond, R. J. Laham, W. Li, M. Pike, F. W. Sellke, et al.
Clinical Trials in Coronary Angiogenesis: Issues, Problems, Consensus : An Expert Panel Summary
Circulation, September 12, 2000; 102 (11): e73 - e86.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
M. Meier and G. L King
Protein kinase C activation and its pharmacological inhibition in vascular disease
Vascular Medicine, August 1, 2000; 5(3): 173 - 185.
[Abstract] [PDF]

Home page
 IOVSHome page
H. Sone, B. K. Deo, and A. K. Kumagai
Enhancement of Glucose Transport by Vascular Endothelial Growth Factor in Retinal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., June 1, 2000; 41(7): 1876 - 1884.
[Abstract] [Full Text]

Home page
 Am. J. Pathol.Home page
K. Miyamoto, S. Khosrof, S.-E. Bursell, Y. Moromizato, L. P. Aiello, Y. Ogura, and A. P. Adamis
Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1)
Am. J. Pathol., May 1, 2000; 156(5): 1733 - 1739.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. W. Cohen, J. M. Carbajal, and R. C. Schaeffer Jr.
VEGF stimulates tyrosine phosphorylation of beta -catenin and small-pore endothelial barrier dysfunction
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H2038 - H2049.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Yoshiji, S. Kuriyama, D. K. Ways, J. Yoshii, Y. Miyamoto, M. Kawata, Y. Ikenaka, H. Tsujinoue, T. Nakatani, M. Shibuya, et al.
Protein Kinase C Lies on the Signaling Pathway for Vascular Endothelial Growth Factor-mediated Tumor Development and Angiogenesis
Cancer Res., September 1, 1999; 59(17): 4413 - 4418.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. A. Antonetti, A. J. Barber, L. A. Hollinger, E. B. Wolpert, and T.